FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161458931> ?p ?o ?g. }

• W3161458931 endingPage "1251" @default.
• W3161458931 startingPage "1243" @default.
• W3161458931 abstract "Latent autoimmune diabetes of adults (LADA) is typically defined as a new diabetes diagnosis after 35 years of age, presenting with clinical features of type 2 diabetes, in whom a type 1 diabetes–associated islet autoantibody is detected. Identifying autoimmune diabetes is important since the prognosis and optimal therapy differ. However, the existing LADA definition identifies a group with clinical and genetic features intermediate between typical type 1 and type 2 diabetes. It is unclear whether this is due to 1) true autoimmune diabetes with a milder phenotype at older onset ages that initially appears similar to type 2 diabetes but later requires insulin, 2) a disease syndrome where the pathophysiologies of type 1 and type 2 diabetes are both present in each patient, or 3) a heterogeneous group resulting from difficulties in classification. Herein, we suggest that difficulties in classification are a major component resulting from defining LADA using a diagnostic test—islet autoantibody measurement—with imperfect specificity applied in low-prevalence populations. This yields a heterogeneous group of true positives (autoimmune type 1 diabetes) and false positives (nonautoimmune type 2 diabetes). For clinicians, this means that islet autoantibody testing should not be undertaken in patients who do not have clinical features suggestive of autoimmune diabetes: in an adult without clinical features of type 1 diabetes, it is likely that a single positive antibody will represent a false-positive result. This is in contrast to patients with features suggestive of type 1 diabetes, where false-positive results will be rare. For researchers, this means that current definitions of LADA are not appropriate for the study of autoimmune diabetes in later life. Approaches that increase test specificity, or prior likelihood of autoimmune diabetes, are needed to avoid inclusion of participants who have nonautoimmune (type 2) diabetes. Improved classification will allow improved assignment of prognosis and therapy as well as an improved cohort in which to analyze and better understand the detailed pathophysiological components acting at onset and during disease progression in late-onset autoimmune diabetes." @default.
• W3161458931 created "2021-05-24" @default.
• W3161458931 creator A5036287780 @default.
• W3161458931 creator A5046281941 @default.
• W3161458931 creator A5048734090 @default.
• W3161458931 creator A5060736941 @default.
• W3161458931 creator A5073846514 @default.
• W3161458931 date "2021-06-01" @default.
• W3161458931 modified "2023-10-14" @default.
• W3161458931 title "Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes" @default.
• W3161458931 cites W1050125050 @default.
• W3161458931 cites W1963486724 @default.
• W3161458931 cites W1966670737 @default.
• W3161458931 cites W1969080742 @default.
• W3161458931 cites W1972182005 @default.
• W3161458931 cites W1981009470 @default.
• W3161458931 cites W1981490811 @default.
• W3161458931 cites W1981742904 @default.
• W3161458931 cites W1991909333 @default.
• W3161458931 cites W1993249613 @default.
• W3161458931 cites W2007268881 @default.
• W3161458931 cites W2008443993 @default.
• W3161458931 cites W2019972832 @default.
• W3161458931 cites W2021990477 @default.
• W3161458931 cites W2049583719 @default.
• W3161458931 cites W2052669556 @default.
• W3161458931 cites W2059471307 @default.
• W3161458931 cites W2070972996 @default.
• W3161458931 cites W2072652145 @default.
• W3161458931 cites W2084215480 @default.
• W3161458931 cites W2084265620 @default.
• W3161458931 cites W2090432138 @default.
• W3161458931 cites W2098739800 @default.
• W3161458931 cites W2099852272 @default.
• W3161458931 cites W2101743642 @default.
• W3161458931 cites W2114189127 @default.
• W3161458931 cites W2117451562 @default.
• W3161458931 cites W2118607432 @default.
• W3161458931 cites W2135617483 @default.
• W3161458931 cites W2137638424 @default.
• W3161458931 cites W2140740027 @default.
• W3161458931 cites W2148941841 @default.
• W3161458931 cites W2151688741 @default.
• W3161458931 cites W2152161585 @default.
• W3161458931 cites W2167007291 @default.
• W3161458931 cites W2399585271 @default.
• W3161458931 cites W2601656250 @default.
• W3161458931 cites W2606216134 @default.
• W3161458931 cites W2617402993 @default.
• W3161458931 cites W2752569040 @default.
• W3161458931 cites W2774874882 @default.
• W3161458931 cites W2794902101 @default.
• W3161458931 cites W2795905061 @default.
• W3161458931 cites W2893903094 @default.
• W3161458931 cites W2896006385 @default.
• W3161458931 cites W2898101053 @default.
• W3161458931 cites W2931041490 @default.
• W3161458931 cites W2967824496 @default.
• W3161458931 cites W2977126534 @default.
• W3161458931 cites W2986133512 @default.
• W3161458931 cites W3080476633 @default.
• W3161458931 doi "https://doi.org/10.2337/dc20-2834" @default.
• W3161458931 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8247509" @default.
• W3161458931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34016607" @default.
• W3161458931 hasPublicationYear "2021" @default.
• W3161458931 type Work @default.
• W3161458931 sameAs 3161458931 @default.
• W3161458931 citedByCount "44" @default.
• W3161458931 countsByYear W31614589312021 @default.
• W3161458931 countsByYear W31614589312022 @default.
• W3161458931 countsByYear W31614589312023 @default.
• W3161458931 crossrefType "journal-article" @default.
• W3161458931 hasAuthorship W3161458931A5036287780 @default.
• W3161458931 hasAuthorship W3161458931A5046281941 @default.
• W3161458931 hasAuthorship W3161458931A5048734090 @default.
• W3161458931 hasAuthorship W3161458931A5060736941 @default.
• W3161458931 hasAuthorship W3161458931A5073846514 @default.
• W3161458931 hasBestOaLocation W31614589311 @default.
• W3161458931 hasConcept C126322002 @default.
• W3161458931 hasConcept C134018914 @default.
• W3161458931 hasConcept C159654299 @default.
• W3161458931 hasConcept C163764329 @default.
• W3161458931 hasConcept C203014093 @default.
• W3161458931 hasConcept C2777180221 @default.
• W3161458931 hasConcept C2779075594 @default.
• W3161458931 hasConcept C2779134260 @default.
• W3161458931 hasConcept C2779668308 @default.
• W3161458931 hasConcept C2780130043 @default.
• W3161458931 hasConcept C2781232474 @default.
• W3161458931 hasConcept C2908647359 @default.
• W3161458931 hasConcept C2908810637 @default.
• W3161458931 hasConcept C555293320 @default.
• W3161458931 hasConcept C71924100 @default.
• W3161458931 hasConcept C99454951 @default.
• W3161458931 hasConceptScore W3161458931C126322002 @default.
• W3161458931 hasConceptScore W3161458931C134018914 @default.
• W3161458931 hasConceptScore W3161458931C159654299 @default.
• W3161458931 hasConceptScore W3161458931C163764329 @default.

• next